ScienceDex / Researcher record
Xiao-Ou Shu
- Vanderbilt University Medical Center (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- R01 Holder
- Top 10% Funded
- Early Career
- Mentor
- Diverse Portfolio
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $5,658,953 | 9 | #924 |
| 2025 | $5,612,873 | 9 | #1,153 |
| 2026 | $14,780,960 | 11 | #367 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20249 records
- FY2025 · selected9 records
- FY202611 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1894075Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-0711-8314Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2025 award records by amount
NIH award records listing Xiao-Ou Shu as a PI. Multi-PI records show the full award amount for context.
- 5UH3CA260318-05UH3Co-investigatorCAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan$2.2Maward amount
- 5R01CA275864-03R01Co-investigatorGut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery$724.9Kaward amount
- 5R01CA293996-02R01Co-investigatorIdentification of proteins for breast cancer risk: an integrative epidemiologic and genomic study$722.6Kaward amount
- 5U01CA262678-04U01Contact PISearching the blood metabolome to identify risk biomarkers for biliary tract cancer$702.7Kaward amount
- 5T32CA160056-14T32Contact PIVanderbilt Training Program in Molecular and Genetic Epidemiology of Cancer$404.9Kaward amount
- $339.8Kaward amount
- 5D43TW012727-02D43Co-investigatorVANDERBILT-VIETNAM TRAINING PROGRAM IN GENETIC EPIDEMIOLOGY$248.4Kaward amount
- 3D43CA270474-04S1D43Contact PIVanderbilt-Zambia Cancer Research Training Program (VZCARE)$138.4Kaward amount
- 5D43CA270474-04D43Contact PIVanderbilt-Zambia Cancer Research Training Program (VZCARE)$130.1Kaward amount
Award organization
Organizations that administered FY2025 awards listing Xiao-Ou Shu as a PI.
FY2025 award administered by Vanderbilt University Medical Center (TN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardVanderbilt University Medical Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #924
- 2024Entered Top 25% NationallyRanked #924
- 2024Entered Top 10% NationallyRanked #924
- 2024Entered Top 5% NationallyRanked #924
- 2025$10M Cumulative Funding
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$25M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Xiao-Ou Shu.